GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Corix Bioscience Inc (GREY:CXBS) » Definitions » Total Assets

Corix Bioscience (Corix Bioscience) Total Assets : $4.34 Mil (As of Sep. 2017)


View and export this data going back to 2008. Start your Free Trial

What is Corix Bioscience Total Assets?

Corix Bioscience's Total Assets for the quarter that ended in Sep. 2017 was $4.34 Mil.

Total Assets is connected with ROA %. Corix Bioscience's annualized ROA % for the quarter that ended in Sep. 2017 was -169.72%. Total Assets is also linked to Revenue through Asset Turnover. Corix Bioscience's Asset Turnover for the quarter that ended in Sep. 2017 was 0.00.


Corix Bioscience Total Assets Historical Data

The historical data trend for Corix Bioscience's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corix Bioscience Total Assets Chart

Corix Bioscience Annual Data
Trend Jan09 Jan10 Jan11 Jan12 Jan13 Jan14 Jan15 Dec16
Total Assets
Get a 7-Day Free Trial - - - - 11.37

Corix Bioscience Quarterly Data
Oct12 Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.05 11.37 - 10.46 4.34

Corix Bioscience Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Corix Bioscience's Total Assets for the fiscal year that ended in Dec. 2016 is calculated as

Total Assets=Total Equity (A: Dec. 2016 )+Total Liabilities (A: Dec. 2016 )
=5.606+5.764
=11.37

Corix Bioscience's Total Assets for the quarter that ended in Sep. 2017 is calculated as

Total Assets=Total Equity (Q: Sep. 2017 )+Total Liabilities (Q: Sep. 2017 )
=3.558+0.786
=4.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Corix Bioscience  (GREY:CXBS) Total Assets Explanation

Total Assets is connected with ROA %.

Corix Bioscience's annualized ROA % for the quarter that ended in Sep. 2017 is

ROA %=Net Income (Q: Sep. 2017 )/( (Total Assets (Q: Jun. 2017 )+Total Assets (Q: Sep. 2017 ))/ count )
=-12.56/( (10.457+4.344)/ 2 )
=-12.56/7.4005
=-169.72 %

Note: The Net Income data used here is four times the quarterly (Sep. 2017) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Corix Bioscience's Asset Turnover for the quarter that ended in Sep. 2017 is

Asset Turnover
=Revenue (Q: Sep. 2017 )/( (Total Assets (Q: Jun. 2017 )+Total Assets (Q: Sep. 2017 ))/ count )
=0/( (10.457+4.344)/ 2 )
=0/7.4005
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Corix Bioscience Total Assets Related Terms

Thank you for viewing the detailed overview of Corix Bioscience's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Corix Bioscience (Corix Bioscience) Business Description

Traded in Other Exchanges
N/A
Address
18662 MaCaurther Boulevard, Suite 200, Irvine, CA, USA, 85085
Corix Bioscience Inc is a United States-based research and development firm of cannabidiol (CBD) products and treatments. It is engaged in the business of producing organic CBD oil used for medical applications and treatments. In addition, the group is also focused on the production of tetrahydrocannabivarin oil. The company is focused on operations in Oregon, California, and Nevada, United States.

Corix Bioscience (Corix Bioscience) Headlines

No Headlines